Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Wouter H. van Geffen, Kevin Lamote, Adrien Costantini, Lizza E.L. Hendriks, Najib M. Rahman, Torsten G. Blum, Jan van Meerbeeck. The electronic nose: emerging biomarkers in lung cancer diagnostics. Breathe, 15 (4) e135; 10.1183/20734735.0309-2019

Member's Comments

No comment yet.

Related content which might interest you: Role of biomarkers for early detection of lung cancer and chemoprevention Source: Eur Respir J 2002; 19: 1151-1158 Year: 2002 Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021 Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013 New findings in the molecular biology of lung cancer: clinical application Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Cytological diagnostics of lung cancer: our experience Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005 Detecting subtypes of non-small cell lung cancer by electronic nose. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Issues other than tissue: non-invasive biomarkers of early stage lung cancer Source: Virtual Congress 2020 – Will the pulmonologist still play a role in the management of screen-detected pulmonary nodules? Year: 2020 Complexity of diagnostics of complicated lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Modern molecular lung cancer diagnostics – how to use and interpret it wisely Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 The x-ray diagnostics of complicated lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 75s Year: 2006 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Potential use of artificial nose in diagnosis and monitoring of different lung diseases Source: Eur Respir J 2007; 30: Suppl. 51, 532s Year: 2007 Detection of small cell lung cancer by electronic nose. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018